Muir A B, Benitez A J, Dods K, Spergel J M, Fillon S A
Division of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Allergy. 2016 Sep;71(9):1256-63. doi: 10.1111/all.12943. Epub 2016 Jun 23.
The prevalence of allergic conditions has continuously increased in the last few decades in Westernized countries. A dysbiotic gut microbiome may play an important role in the development of allergic diseases. Genetic, environmental, and dietary factors may alter the commensal microbiota leading to inflammatory dysregulation of homeostasis. Murine and human studies have begun to elucidate the role of the microbiota in the pathogenesis of atopic diseases including asthma, atopic dermatitis, and food allergies. However, the role of the microbiome in most eosinophilic gastrointestinal diseases (EGIDs) is not yet known. This review provides an overview of what is currently known about the development of tolerance from both molecular and clinical standpoints. We also look at the gut-specific microbiome and its role in atopic conditions with the hope of applying this knowledge to the understanding, prevention, and treatment of EGIDs, particularly EoE.
在过去几十年中,西方国家过敏性疾病的患病率持续上升。肠道微生物群失调可能在过敏性疾病的发展中起重要作用。遗传、环境和饮食因素可能会改变共生微生物群,导致体内稳态的炎症调节异常。小鼠和人体研究已开始阐明微生物群在特应性疾病(包括哮喘、特应性皮炎和食物过敏)发病机制中的作用。然而,微生物群在大多数嗜酸性粒细胞性胃肠道疾病(EGIDs)中的作用尚不清楚。本综述从分子和临床角度概述了目前已知的耐受性发展情况。我们还研究了肠道特异性微生物群及其在特应性疾病中的作用,希望将这些知识应用于EGIDs尤其是嗜酸性粒细胞性食管炎(EoE)的理解、预防和治疗。